Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03716531 · ClinicalTrials.gov registry record · NA
Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement
A NA study of Pancreas Cancer, sponsored by Massachusetts General Hospital.
- Active
- Registry status
- NA
- Development phase
- 199
- Enrollment target
- 6
- Study locations
NCT03716531: Active NA study of Pancreas Cancer, sponsored by Massachusetts General Hospital.
NCT03716531 is a NA study of Pancreas Cancer that is active but no longer recruiting, run by Massachusetts General Hospital. The registered enrollment target is 199 participants, below the 904-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (78% lower). The trial reports 6 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03716531, a NA study of Pancreas Cancer, is active but no longer recruiting, sponsored by Massachusetts General Hospital.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 199 participants
- Enrollment target
- 6
- Study locations
Study Summary
This research study is studying an intervention as a possible treatment for pancreatic cancer.
Primary Outcome
Overall survival is defined as the time from IORT to death due to any cause, or is censored at the date of last follow-up, when applicable.
Conditions Studied
Interventions
- RADIATION IORT
Study Locations (6)
California
- University of California, Irvine - Irvine
Florida
- Mayo Clinic, Jacksonville - Jacksonville
Massachusetts
- Massachusetts General Hospital - Boston
Minnesota
- Mayo Clinic, Rochester - Rochester
North Carolina
- University of North, Carolina Chapel Hill - Chapel Hill
Ohio
- Ohio State University Medical Center - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2019-03-19 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What the registry record for NCT03716531 still lists
NCT03716531 is an interventional study that assigns participants to a tested intervention. The registered 199 participants enrollment target is mid-sized for trials with a published cap, below the 904-participant average among 54 other Pancreas Cancer trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Pancreas Cancer appearing as the primary indexed condition, and to 1 intervention - of which IORT is the first listed.
NCT03716531 lists 6 locations in 6 states (California, Florida, Massachusetts).
Frequently Asked Questions
What is clinical trial NCT03716531 about?
NCT03716531 is a clinical study titled "Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement". This research study is studying an intervention as a possible treatment for pancreatic cancer.
What is the current status of trial NCT03716531?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 199 participants. The study started on 2019-03-19. Estimated completion is 2027-12-31.
What conditions does trial NCT03716531 study?
This clinical trial studies the following conditions: Pancreas Cancer.
What interventions are being tested in trial NCT03716531?
The interventions under investigation include: IORT (RADIATION).
Who is sponsoring clinical trial NCT03716531?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03716531 being conducted?
This trial has 6 study locations across California, Florida, Massachusetts, Minnesota, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreas Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03716531's enrollment target sits among peer trials
199 17th of 54 higher than 38 of 54 other Pancreas Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pancreas Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
-
Promoting CT Engagement for Pancreatic Cancer With App
RECRUITING · NA
-
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
RECRUITING · NA
-
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence
RECRUITING · NA
-
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
RECRUITING · NA
-
EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04312126 · 199 participants
The Beneficial Effects of Naps on Motor Learning
- NCT04951622 · 199 participants · Phase 3
A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis
- NCT06474533 · 199 participants
Fluoroethyltyrosine for the Evaluation of Intracranial Neoplasm
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI